Tumor inhibition of poly(2-oxazoline)-paclitaxel formulations in advanced tumor models evaluated against clinical paclitaxel formulations

Research output: Contribution to journal › Meeting abstract › Contributed › peer-review

Contributors

  • Robert Luxenhofer - , University of Würzburg (Author)
  • Zhijian He - , University of North Carolina at Chapel Hill (Author)
  • Anita Schulz - , Chair of Macromolecular Chemistry (Author)
  • Xiaomeng Wan - , University of North Carolina at Chapel Hill (Author)
  • Rainer Jordan - , Chair of Macromolecular Chemistry (Author)
  • Alexander Kabanov - , University of North Carolina at Chapel Hill (Author)

Details

Original languageEnglish
Article number279
Number of pages2
JournalACS national meeting
Volume252
Publication statusPublished - 20 Aug 2016
Peer-reviewedYes

External IDs

WOS 000431460404219

Keywords